INVN - ETF AI Analysis
Top Page
Alger Russell Innovation ETF (INVN)
INVN, the Alger Russell Innovation ETF, earns a solid overall rating thanks to several innovative leaders like Meta Platforms and DocuSign, which bring strong financial performance, positive earnings sentiment, and strategic focus on AI and growth. However, holdings such as Roblox and Nutanix, which face profitability challenges, high leverage, and bearish technical trends, weigh on the fund’s score. The main risk factor is the fund’s concentration in high-growth, innovation-focused companies that often come with valuation concerns and uneven profitability.
INVN vs. SPDR S&P 500 ETF (SPY)
- AUM
- 10.84M
- Region
- North America
- Expense Ratio
- 0.55%
- Beta
- 1.00
- Issuer
- Alger
- Inception Date
- Jan 07, 2025
- Dividend Yield
- 0.23%
- Asset Class
- Equity
- Index Tracked
- Alger Russell Innovation Index
INVN Summary
Alger Russell Innovation ETF (INVN) is an exchange-traded fund that follows the Alger Russell Innovation Index, focusing mainly on large U.S. companies driving new technology and ideas. It is heavily invested in tech and health care, with well-known names like Roblox and DocuSign among its top holdings. Someone might invest in INVN to seek long-term growth and to spread their money across many innovative businesses instead of picking individual stocks. A key risk is that, because it leans strongly toward technology and other fast-changing sectors, its price can rise and fall sharply with market swings and shifts in investor sentiment.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 invested. That’s higher than the average cost of a simple index (passive) ETF because this fund is actively managed, with professionals selecting innovative large-cap companies for the portfolio.
What would affect this ETF?
This ETF is heavily invested in U.S. technology and health care innovators, so it could benefit if new digital tools, online platforms, and medical breakthroughs gain wider adoption and if a strong U.S. economy supports large, fast-growing companies like Meta, Roblox, and Biogen. On the other hand, it could be hurt by rising interest rates that make growth stocks less attractive, tighter rules on tech and online platforms, or an economic slowdown that pressures communication services and consumer-focused companies such as Pinterest and Etsy.
INVN Top 10 Holdings
INVN is leaning hard into U.S. software and cloud innovators, with names like Atlassian, GitLab, Elastic, and RingCentral doing most of the heavy lifting. These tech leaders have been rising lately, helped by enthusiasm around AI and subscription-based growth, though some are bumping into valuation and profitability speed bumps. Maplebear adds a consumer-tech twist with steady, upbeat momentum, while biotech holdings like Biogen and Exelixis provide a healthier counterbalance and have been quietly climbing. Overall, it’s a tech-heavy, U.S.-centric bet on innovation, with a few laggards like Roblox losing steam.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 RBLX | Roblox | 2.55% | $277.20K | $30.77B | -61.96% | 51Neutral |
 DOCU | DocuSign | 2.50% | $271.53K | $15.36B | 14.75% | 71Outperform |
 ESTC | Elastic | 2.31% | $251.02K | $10.31B | 10.06% | 65Neutral |
 RNG | RingCentral | 2.31% | $251.10K | $6.88B | 176.19% | 63Neutral |
 TEAM | Atlassian | 2.19% | $238.39K | $48.29B | 19.33% | 66Neutral |
 GTLB | Gitlab | 2.29% | $248.69K | $9.01B | 13.92% | 62Neutral |
 CART | Maplebear | 2.22% | $241.29K | $13.07B | 54.02% | 79Outperform |
 EXEL | Exelixis | 2.26% | $246.26K | $16.93B | 78.20% | 78Outperform |
 ETSY | Etsy | 2.24% | $244.00K | $7.67B | 43.65% | 57Neutral |
 BIIB | Biogen | 2.24% | $244.16K | $37.49B | 69.52% | 74Outperform |
INVN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For INVN, the sentiment is Neutral. The current price of 26.74 is above the 20-day moving average (MA) of 26.71, above the 50-day MA of 26.42, and above the 200-day MA of 22.29, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 51.12 is Neutral, neither overbought nor oversold. The STOCH value of 44.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for INVN.
INVN Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| INVN | $26.74 | $29.00(8.47% Upside) | $10.84M | 0.55% | 69Neutral |
 PRMR | $28.30 | $34.26(21.03% Upside) | $93.63M | 1.00% | 73Outperform |
 SPXE | $80.85 | $100.63(24.47% Upside) | $86.64M | 0.09% | 74Outperform |
 FCUS | $36.61 | $47.35(29.34% Upside) | $86.02M | 0.80% | 67Neutral |
 NULC | $54.91 | $68.55(24.84% Upside) | $81.33M | 0.21% | 74Outperform |
 QARP | $68.79 | $80.14(16.49% Upside) | $79.50M | 0.19% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| INVN | Alger Russell Innovation ETF | 26.74 | 5.59 | 26.45% | |
| PRMR | PeakShares RMR Prime Equity ETF | 28.30 | 3.32 | 13.31% | |
| SPXE | ProShares S&P 500 Ex-Energy ETF | 80.85 | 7.60 | 10.37% | |
| FCUS | Pinnacle Focused Opportunities ETF | 36.61 | 2.64 | 7.78% | |
| NULC | Nuveen ESG Large-Cap ETF | 54.91 | 7.00 | 14.61% | |
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 68.79 | 11.60 | 20.27% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.